Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gucishangtongtie is a Traditional Chinese Medicine (TCM) topical plaster (patch) primarily indicated for the treatment of pain and inflammation associated with bone hyperplasia (osteophytes), cervical spondylosis, and osteoarthritis. Developed and manufactured by Hangzhou Tiancheng Pharmaceutical Co., Ltd., the formulation typically consists of a complex mixture of herbal ingredients, including *Radix Aconiti* (Chuanwu), *Radix Aconiti Kusnezoffii* (Caowu), *Rheum palmatum* (Dahuang), Camphor, and Menthol. The therapeutic mechanism involves the topical absorption of active alkaloids and volatile oils that promote local blood circulation, dispel "wind-cold-dampness" (according to TCM theory), and provide analgesic effects by modulating pain receptors and inflammatory mediators. It is widely used in clinical practice in China for chronic musculoskeletal conditions characterized by joint stiffness and localized pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gucishangtongtie.